1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 73, 2022
  5. Article

Annual Review of Medicine

Volume 73, 2022

Endoscopic Approaches to Obesity Management

Abstract

The field of endoscopic bariatric and metabolic therapy has rapidly evolved from offering endoscopic treatment of weight regain following bariatric surgery to providing primary weight loss options as alternatives to pharmacologic and surgical interventions. Gastric devices and remodeling procedures were initially designed to work through a mechanism of volume restriction, leading to earlier satiety and reduced caloric intake. As the field continues to grow, small bowel interventions are evolving that may have some effect on weight loss but focus on the treatment of obesity-related comorbidities. Future implementation of combination therapy that utilizes both gastric and small bowel interventions offers an exciting option to further augment weight loss and alleviate metabolic disease. This review considers gastric devices and techniques including space-occupying intragastric balloons, aspiration therapy, endoscopic tissue suturing, and plication interventions, followed by a review of small bowel interventions including endoluminal bypass liners, duodenal mucosal resurfacing, and endoscopically delivered devices to create incisionless anastomoses.

Keyword(s): EBMT, endoscopic bariatric and metabolic therapy, endoscopic sleeve gastroplasty, ESG, intragastric balloon, obesity
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-042320-125832
2022-01-27
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/med/73/1/annurev-med-042320-125832.html?itemId=/content/journals/10.1146/annurev-med-042320-125832&mimeType=html&fmt=ahah

Literature Cited

  1. 1. 
    Hales CM, Fryar CD, Ogden CL. 2020. Prevalence of obesity and severe obesity among adults: United States, 2017–2018 NCHS Data Brief 360 Natl. Cent. Health Stat. Hyattsville, MD:
     [Google Scholar]
  2. 2. 
    Pantalone KM, Hobbs TM, Chagin KM et al. 2017. Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open 7:11e017583
     [Google Scholar]
  3. 3. 
    Stenholm S, Head J, Kivimäki M et al. 2016. Smoking, physical inactivity and obesity as predictors of healthy and disease-free life expectancy between ages 50 and 75: a multicohort study. Int. J. Epidemiol. 45:41260–70
     [Google Scholar]
  4. 4. 
    Apovian CM, Aronne LJ, Bessesen DH et al. 2015. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 100:2342–62
     [Google Scholar]
  5. 5. 
    Jensen MD, Ryan DH, Donato KA et al. 2014. Executive summary: guidelines (2013) for the management of overweight and obesity in adults. Obesity 22:Suppl. 2S5–S39
     [Google Scholar]
  6. 6. 
    Webb VL, Wadden TA. 2017. Intensive lifestyle intervention for obesity: principles, practices, and results. Gastroenterology 152:71752–64
     [Google Scholar]
  7. 7. 
    English WJ, DeMaria EJ, Hutter MM et al. 2020. American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg. Obes. Relat. Dis. 16:4457–63
     [Google Scholar]
  8. 8. 
    Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. 2020. Benefits and risks of bariatric surgery in adults: a review. JAMA 324:9879–87
     [Google Scholar]
  9. 9. 
    Monaco-Ferreira DV, Leandro-Merhi VA. 2017. Weight regain 10 years after Roux-en-Y gastric bypass. Obes. Surg 27:51137–44
     [Google Scholar]
  10. 10. 
    Sjöström L, Narbro K, Sjöström CD et al. 2007. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357:8741–52
     [Google Scholar]
  11. 11. 
    Bastos EC, Barbosa EM, Soriano GM et al. 2013. Determinants of weight regain after bariatric surgery. Arq. Bras. Cir. Dig. 26:Suppl. 126–32
     [Google Scholar]
  12. 12. 
    Felsenreich DM, Langer FB, Kefurt R et al. 2016. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg. Obes. Relat. Dis. 12:91655–62
     [Google Scholar]
  13. 13. 
    Glaysher MA, Mohanaruban A, Prechtl CG et al. 2017. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. BMJ Open 7:11e018598
     [Google Scholar]
  14. 14. 
    Lopez-Nava G, Negi A, Bautista-Castaño I et al. 2020. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) versus laparoscopic sleeve gastrectomy (LSG). Obes. Surg 30:72642–51
     [Google Scholar]
  15. 15. 
    Salomone F, Sharaiha RZ, Boškoski I. 2020. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: evidence and perspectives. Liver Int 40:61262–68
     [Google Scholar]
  16. 16. 
    Rubino F, Forgione A, Cummings DE et al. 2006. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann. Surg. 244:5741–49
     [Google Scholar]
  17. 17. 
    Bazerbachi F, Vargas EJ, Abu Dayyeh BK. 2019. Endoscopic bariatric therapy: a guide to the intragastric balloon. Am. J. Gastroenterol. 114:91421–31
     [Google Scholar]
  18. 18. 
    Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. 2007. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg. Obes. Relat. Dis. 3:2109–15
     [Google Scholar]
  19. 19. 
    Patriti A, Aisa MC, Annetti C et al. 2007. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery 142:174–85
     [Google Scholar]
  20. 20. 
    Gleysteen JJ. 2016. A history of intragastric balloons. Surg. Obes. Relat. Dis. 12:2430–35
     [Google Scholar]
  21. 21. 
    Muniraj T, Day LW, Teigen LM et al. 2021. AGA clinical practice guidelines on intragastric balloons in the management of obesity. Gastroenterology 160:51799–808
     [Google Scholar]
  22. 22. 
    Bazerbachi F, Haffar S, Sawas T et al. 2018. Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomized trials. Obes. Surg. 28:92617–25
     [Google Scholar]
  23. 23. 
    Patel NJ, Gómez V, Steidley DE et al. 2020. Successful use of intragastric balloon therapy as a bridge to heart transplantation. Obes. Surg. 30:93610–14
     [Google Scholar]
  24. 24. 
    Zerrweck C, Maunoury V, Caiazzo R et al. 2012. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes. Surg. 22:5777–82
     [Google Scholar]
  25. 25. 
    Abu Dayyeh BK, Eaton LL, Woodman G et al. 2015. A randomized, multi-center study to evaluate the safety and effectiveness of an intragastric balloon as an adjunct to a behavioral modification program, in comparison with a behavioral modification program alone in the weight management of obese subjects. Gastrointest. Endosc. 81:5 SupplAB147. Abstr.
     [Google Scholar]
  26. 26. 
    Vargas EJ, Pesta CM, Bali A et al. 2018. Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population. Clin. Gastroenterol. Hepatol. 16:71073–80.e1
     [Google Scholar]
  27. 27. 
    Abu Dayyeh BK, Kumar N, Edmundowicz SA et al. 2015. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest. Endosc. 82:3425–38.e5
     [Google Scholar]
  28. 28. 
    Neto MG, Silva LB, Grecco E et al. 2018. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg. Obes. Relat. Dis. 14:2151–59
     [Google Scholar]
  29. 29. 
    Courcoulas A, Abu Dayyeh BK, Eaton L et al. 2017. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int. J. Obes. 41:3427–33
     [Google Scholar]
  30. 30. 
    Ponce J, Woodman G, Swain J et al. 2015. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg. Obes. Relat. Dis. 11:4874–81
     [Google Scholar]
  31. 31. 
    Agnihotri A, Xie A, Bartalos C et al. 2018. Real-world safety and efficacy of fluid-filled dual intragastric balloon for weight loss. Clin. Gastroenterol. Hepatol. 16:71081–88.e1
     [Google Scholar]
  32. 32. 
    Sullivan S, Swain J, Woodman G et al. 2018. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg. Obes. Relat. Dis. 14:121876–89
     [Google Scholar]
  33. 33. 
    Mion F, Ibrahim M, Marjoux S et al. 2013. Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes. Surg. 23:5730–33
     [Google Scholar]
  34. 34. 
    Machytka E, Klvana P, Kornbluth A et al. 2011. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes. Surg. 21:101499–507
     [Google Scholar]
  35. 35. 
    Brooks J, Srivastava ED, Mathus-Vliegen EM. 2014. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes. Surg. 24:5813–19
     [Google Scholar]
  36. 36. 
    Russo T, Aprea G, Formisano C et al. 2017. BioEnterics Intragastric Balloon (BIB) versus Spatz Adjustable Balloon System (ABS): our experience in the elderly. Int. J. Surg. 38:138–40
     [Google Scholar]
  37. 37. 
    Daniel F, Abou Fadel C, Houmani Z, Salti N 2016. Spatz 3 adjustable intragastric balloon: long-term safety concerns. Obes. Surg. 26:159–60
     [Google Scholar]
  38. 38. 
    Machytka E, Gaur S, Chuttani R, Bojkova M et al. 2017. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy 49:2154–60
     [Google Scholar]
  39. 39. 
    Alsabah S, Al Haddad E, Ekrouf S et al. 2018. The safety and efficacy of the procedureless intragastric balloon. Surg. Obes. Relat. Dis. 14:3311–17
     [Google Scholar]
  40. 40. 
    Jamal MH, Almutairi R, Elabd R et al. 2019. The safety and efficacy of procedureless gastric balloon: a study examining the effect of elipse intragastric balloon safety, short and medium term effects on weight loss with 1-year follow-up post-removal. Obes. Surg. 29:41236–41
     [Google Scholar]
  41. 41. 
    Marinos G, Eliades C, Muthusamy VR, Greenway F 2014. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg. Obes. Relat. Dis. 10:5929–34
     [Google Scholar]
  42. 42. 
    Rothstein RI, Woodman G, Swain J, de La Cruz N et al. 2019. Transpyloric shuttle treatment improves cardiometabolic risk factors and quality of life in patients with obesity: results from a randomized, double-blind, sham-controlled trial. Gastroenterology 156:6S–237
     [Google Scholar]
  43. 43. 
    Abu Dayyeh BK, Acosta A, Camilleri M et al. 2017. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin. Gastroenterol. Hepatol. 15:137–43.e1
     [Google Scholar]
  44. 44. 
    Espinet-Coll E, Nebreda-Durán J, Galvao-Neto M, Bautista-Altamirano C et al. 2020. Suture pattern does not influence outcomes of endoscopic sleeve gastroplasty in obese patients. Endosc. Int. Open 8:10e1349–58
     [Google Scholar]
  45. 45. 
    Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G et al. 2018. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg. Endosc. 32:42159–64
     [Google Scholar]
  46. 46. 
    Lopez-Nava G, Sharaiha RZ, Vargas EJ et al. 2017. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes. Surg. 27:102649–55
     [Google Scholar]
  47. 47. 
    Alqahtani A, Al-Darwish A, Mahmoud AE et al. 2019. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest. Endosc. 89:61132–38
     [Google Scholar]
  48. 48. 
    Sharaiha RZ, Hajifathalian K, Kumar R et al. 2020. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin. Gastroenterol. Hepatol. 19:51051–57.e2
     [Google Scholar]
  49. 49. 
    Alqahtani AR, Elahmedi M, Alqahtani YA, Al-Darwish A. 2019. Laparoscopic sleeve gastrectomy after endoscopic sleeve gastroplasty: technical aspects and short-term outcomes. Obes. Surg. 29:113547–52
     [Google Scholar]
  50. 50. 
    Fayad L, Adam A, Schweitzer M, Cheskin LJ et al. 2019. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest. Endosc. 89:4782–88
     [Google Scholar]
  51. 51. 
    Lopez-Nava G, Bautista-Castano I, Jimenez A et al. 2015. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg. Obes. Relat. Dis. 11:4861–65
     [Google Scholar]
  52. 52. 
    Miller K, Turro R, Greve JW et al. 2017. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after poseSM versus medical therapy. Obes. Surg. 27:2310–22
     [Google Scholar]
  53. 53. 
    Dolan RD, McCarty TR, Jirapinyo P, Thompson CC 2021. Endoscopic revision of gastric bypass using plication technique: an adjustable approach. VideoGIE 6:7311–15
     [Google Scholar]
  54. 54. 
    Thompson CC, Abu Dayyeh BK, Kushner R et al. 2017. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am. J. Gastroenterol. 112:3447–57
     [Google Scholar]
  55. 55. 
    Thompson CC, Abu Dayyeh BK, Kushnir V et al. 2019. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surg. Obes. Relat. Dis. 15:81348–54
     [Google Scholar]
  56. 56. 
    Greenway FL, Aronne LJ, Raben A et al. 2019. A randomized, double-blind, placebo-controlled study of Gelesis100: a novel nonsystemic oral hydrogel for weight loss. Obesity 27:2205–16
     [Google Scholar]
  57. 57. 
    Rajagopalan H, Cherrington AD, Thompson CC et al. 2016. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care 39:122254–61
     [Google Scholar]
  58. 58. 
    van Baar ACG, Holleman F, Crenier L et al. 2020. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut 69:2295–303
     [Google Scholar]
  59. 59. 
    Mingrone G, van Baar AC, Devière J et al. 2021. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut. In press. https://doi.org/10.1136/gutjnl-2020-323608
    [Crossref] [Google Scholar]
  60. 60. 
    Ruban A, Ashrafian H, Teare JP. 2018. The EndoBarrier: duodenal-jejunal bypass liner for diabetes and weight loss. Gastroenterol. Res. Pract. 2018:7823182
     [Google Scholar]
  61. 61. 
    van Rijn S, Roebroek YGM, de Jonge C et al. 2019. Effect of the EndoBarrier device: a 4-year follow-up of a multicenter randomized clinical trial. Obes. Surg. 29:41117–21
     [Google Scholar]
  62. 62. 
    Betzel B, Cooiman MI, Aarts EO et al. 2020. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation. Surg. Endosc. 34:1209–15
     [Google Scholar]
  63. 63. 
    Jirapinyo P, Haas AV, Thompson CC. 2018. Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes. Diabetes Care 41:51106–15
     [Google Scholar]
  64. 64. 
    Sandler BJ, Rumbaut R, Swain CP et al. 2015. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg. Endosc. 29:113298–303
     [Google Scholar]
  65. 65. 
    Sandler BJ, Biertho L, Anvari M et al. 2018. Totally endoscopic implant to effect a gastric bypass: 12-month safety and efficacy outcomes. Surg. Endosc 32:114436–42
     [Google Scholar]
  66. 66. 
    Machytka E, Buzga M, Zonca P et al. 2017. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointest. Endosc. 86:5904–12
     [Google Scholar]
  67. 67. 
    King WC, Hinerman AS, Belle SH et al. 2018. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA 320:151560–69
     [Google Scholar]
  68. 68. 
    van Hout GC, Verschure SK, van Heck GL. 2005. Psychosocial predictors of success following bariatric surgery. Obes. Surg. 15:4552–60
     [Google Scholar]
  69. 69. 
    Perugini RA, Mason R, Czerniach DR et al. 2003. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch. Surg. 138:5541–45
     [Google Scholar]
  70. 70. 
    Odom J, Zalesin KC, Washington TL et al. 2010. Behavioral predictors of weight regain after bariatric surgery. Obes. Surg. 20:3349–56
     [Google Scholar]
  71. 71. 
    Abu Dayyeh BK, Lautz DB, Thompson CC 2011. Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin. Gastroenterol. Hepatol. 9:3228–33
     [Google Scholar]
  72. 72. 
    de Quadros LG, Neto MG, Marchesini JC et al. 2020. Endoscopic argon plasma coagulation versus multidisciplinary evaluation in the management of weight regain after gastric bypass surgery: a randomized controlled trial with sham group. Obes. Surg. 30:51904–16
     [Google Scholar]
  73. 73. 
    Moon RC, Teixeira AF, Neto MG et al. 2018. Efficacy of utilizing argon plasma coagulation for weight regain in Roux-en-Y gastric bypass patients: a multi-center study. Obes. Surg. 28:92737–44
     [Google Scholar]
  74. 74. 
    Baretta GA, Alhinho HC, Matias JE et al. 2015. Argon plasma coagulation of gastrojejunal anastomosis for weight regain after gastric bypass. Obes. Surg. 25:172–79
     [Google Scholar]
  75. 75. 
    Fayad L, Trindade AJ, Benias PC et al. 2020. Cryoballoon ablation for gastric pouch and/or outlet reduction in patients with weight regain post Roux-en-Y gastric bypass. Endoscopy 52:3227–30
     [Google Scholar]
  76. 76. 
    Parsi MA, Trindade AJ, Bhutani MS et al. 2017. Cryotherapy in gastrointestinal endoscopy. VideoGIE 2:589–95
     [Google Scholar]
  77. 77. 
    Abrams JA, Komanduri S, Shaheen NJ et al. 2018. Radiofrequency ablation for the treatment of weight regain after Roux-en-Y gastric bypass surgery. Gastrointest. Endosc. 87:1275–79.e2
     [Google Scholar]
  78. 78. 
    Hollenbach M, Selig L, Lellwitz S et al. 2019. Endoscopic full-thickness transoral outlet reduction with semicircumferential endoscopic submucosal dissection. Endoscopy 51:7684–88
     [Google Scholar]
  79. 79. 
    Jirapinyo P, de Moura DTH, Dong WY et al. 2020. Dose response for argon plasma coagulation in the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest. Endosc. 91:51078–84
     [Google Scholar]
  80. 80. 
    Patel LY, Lapin B, Brown CS et al. 2017. Outcomes following 50 consecutive endoscopic gastrojejunal revisions for weight gain following Roux-en-Y gastric bypass: a comparison of endoscopic suturing techniques for stoma reduction. Surg. Endosc. 31:62667–77
     [Google Scholar]
  81. 81. 
    Heylen AM, Jacobs A, Lybeer M, Prosst RL. 2011. The OTSC®-clip in revisional endoscopy against weight gain after bariatric gastric bypass surgery. Obes. Surg 21:101629–33
     [Google Scholar]
  82. 82. 
    Jirapinyo P, Dayyeh BK, Thompson CC. 2016. Gastrojejunal anastomotic reduction for weight regain in Roux-en-Y gastric bypass patients: physiological, behavioral, and anatomical effects of endoscopic suturing and sclerotherapy. Surg. Obes. Relat. Dis. 12:101810–16
     [Google Scholar]
  83. 83. 
    Riva P, Perretta S, Swanstrom L 2017. Weight regain following RYGB can be effectively treated using a combination of endoscopic suturing and sclerotherapy. Surg. Endosc. 31:41891–95
     [Google Scholar]
  84. 84. 
    Abu Dayyeh BK, Jirapinyo P, Weitzner Z et al. 2012. Endoscopic sclerotherapy for the treatment of weight regain after Roux-en-Y gastric bypass: outcomes, complications, and predictors of response in 575 procedures. Gastrointest. Endosc. 76:2275–82
     [Google Scholar]
  85. 85. 
    Catalano MF, Rudic G, Anderson AJ, Chua TY 2007. Weight gain after bariatric surgery as a result of a large gastric stoma: endotherapy with sodium orrhuate may prevent the need for surgical revision. Gastrointest. Endosc. 66:2240–45
     [Google Scholar]
  86. 86. 
    Jirapinyo P, Thompson CC. 2020. Personalized algorithm for the management of weight regain following Roux-en-Y gastric bypass: suturing versus plication versus argon plasma coagulation. Gastrointest. Endosc. 91:6AB60–AB61 Abstr.
    [Google Scholar]
  87. 87. 
    Jirapinyo P, Kumar N, AlSamman MA, Thompson CC 2020. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest. Endosc. 91:51067–73
     [Google Scholar]
  88. 88. 
    Schulman AR, Kumar N, Thompson CC. 2018. Transoral outlet reduction: a comparison of purse-string with interrupted stitch technique. Gastrointest. Endosc. 87:51222–28
     [Google Scholar]
  89. 89. 
    Jirapinyo P, de Moura DTH, Thompson CC. 2020. Endoscopic submucosal dissection with suturing for the treatment of weight regain after gastric bypass: outcomes and comparison with traditional transoral outlet reduction (with video). Gastrointest. Endosc. 91:61282–88
     [Google Scholar]
  90. 90. 
    de Moura DTH, Barrichello S Jr., de Moura EGH, de Souza TF et al. 2020. Endoscopic sleeve gastroplasty in the management of weight regain after sleeve gastrectomy. Endoscopy 52:3202–10
     [Google Scholar]
  91. 91. 
    English WJ, DeMaria EJ, Brethauer SA, Mattar SG et al. 2018. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg. Obes. Relat. Dis. 14:3259–63
     [Google Scholar]
/content/journals/10.1146/annurev-med-042320-125832
Loading
Endoscopic Approaches to Obesity Management
Annual Review of Medicine 73, 423 (2022); https://doi.org/10.1146/annurev-med-042320-125832
/content/journals/10.1146/annurev-med-042320-125832
/content/journals/10.1146/annurev-med-042320-125832
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error